ESCO1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.031400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.056000E-01
Normal-vs-Stage2
8.527000E-01
Normal-vs-Stage3
6.497700E-02
Normal-vs-Stage4
4.577400E-01
Stage1-vs-Stage2
5.740200E-01
Stage1-vs-Stage3
2.031400E-01
Stage1-vs-Stage4
2.894400E-01
Stage2-vs-Stage3
1.544390E-01
Stage2-vs-Stage4
3.606600E-01
Stage3-vs-Stage4
1.736170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.791200E-01
Normal-vs-AfricanAmerican
8.298000E-01
Normal-vs-Asian
9.708800E-01
Caucasian-vs-AfricanAmerican
9.070800E-01
Caucasian-vs-Asian
5.463800E-01
AfricanAmerican-vs-Asian
8.161000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.895400E-01
Normal-vs-Female
8.291600E-01
Male-vs-Female
7.581600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.945400E-01
Normal-vs-Age(41-60Yrs)
9.115600E-01
Normal-vs-Age(61-80Yrs)
7.423000E-01
Normal-vs-Age(81-100Yrs)
1.560170E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.070200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.473200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.856590E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.182170E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.344300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.296600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.961800E-01
Normal-vs-Daily Drinker
3.660800E-01
Normal-vs-Weekly Drinker
6.553600E-01
Normal-vs-Occasional Drinker
9.750600E-01
Normal-vs-Social Drinker
8.263800E-01
Non Drinker-vs-Daily Drinker
7.876800E-01
Non Drinker-vs-Weekly Drinker
6.281200E-01
Non Drinker-vs-Occasional Drinker
7.359800E-02
Non Drinker-vs-Social Drinker
6.843000E-03
Daily Drinker-vs-Weekly Drinker
7.336000E-01
Daily Drinker-vs-Occasional Drinker
1.387640E-01
Daily Drinker-vs-Social Drinker
4.307800E-02
Weekly Drinker-vs-Occasional Drinker
4.265000E-01
Weekly Drinker-vs-Social Drinker
2.660200E-01
Occasional Drinker-vs-Social Drinker
7.108400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.479640E-01
Normal-vs-Grade 2
3.746100E-02
Normal-vs-Grade 3
4.088400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.026200E-01
Grade 1-vs-Grade 3
1.395840E-01
Grade 1-vs-Grade 4
1.479640E-01
Grade 2-vs-Grade 3
5.745200E-01
Grade 2-vs-Grade 4
3.746100E-02
Grade 3-vs-Grade 4
4.088400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.411000E-01
Normal-vs-NonDiabetic
8.435400E-01
Diabetic-vs-NonDiabetic
4.059800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.213400E-01
Normal-vs-NoPancreatitis
7.356800E-01
Pancreatitis-vs-NoPancreatitis
4.532600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.459000E-01
Normal-vs-N1
8.671600E-01
N0-vs-N1
5.097000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.342000E-01
Normal-vs-TP53-NonMutant
8.822000E-01
TP53-Mutant-vs-TP53-NonMutant
2.904300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
